Dow +0.11% 18868Pts, Nasdaq -0.36 % a 5218pts , S&P -0.01% 2164pts
$CRBP |
|
|
|
|
|
|
Corbus
Pharmaceuticals Holdings Inc |
|
|
|
|
Industria:
Biotecnología |
|
|
|
|
|
Sector:
Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
$CRBP
subio 51.28% a $8.85 , luego de anunciar avances en el tratamiento de la
esclerosis mùltiples
$DVAX |
|
|
|
|
|
|
Dynavax
Technologies Corporation |
|
|
|
|
Industria:
Biotecnologia |
|
|
|
|
|
Sector: Healthcare |
|
|
|
|
|
|
|
|
|
|
|
|
$DVAX bajò 64.66% a
$4.10, despues de anunciar que su ensayo para el tratamiento de la
hepatitis B |
no alcanzò
los objetivos primarios |
|
|
|
|
Otros Stocks: |
|
|
|
|
|
$DRYS
, $EGLE , $HAR , $IDSA , $RSO , $HEAR , $PBYI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|